These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 38324017)

  • 1. Cell-based Therapies for Acute Respiratory Distress Syndrome: Where Are We Now?
    Curley GF; O'Kane CM; McAuley DF; Matthay MA; Laffey JG
    Am J Respir Crit Care Med; 2024 Apr; 209(7):789-797. PubMed ID: 38324017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
    Gorman E; Millar J; McAuley D; O'Kane C
    Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
    [No Abstract]   [Full Text] [Related]  

  • 3. Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome.
    Ringdén O; Moll G; Gustafsson B; Sadeghi B
    Front Immunol; 2022; 13():839844. PubMed ID: 35371003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-based therapies for the acute respiratory distress syndrome.
    Maron-Gutierrez T; Laffey JG; Pelosi P; Rocco PR
    Curr Opin Crit Care; 2014 Feb; 20(1):122-31. PubMed ID: 24300620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS.
    Xu Z; Huang Y; Zhou J; Deng X; He W; Liu X; Li Y; Zhong N; Sang L
    Front Immunol; 2021; 12():738697. PubMed ID: 34659231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell therapy for acute respiratory distress syndrome: a promising future?
    Horie S; Masterson C; Devaney J; Laffey JG
    Curr Opin Crit Care; 2016 Feb; 22(1):14-20. PubMed ID: 26645555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in mesenchymal stem cell-based therapy for acute lung injury.
    Liang J; Dai W; Xue S; Wu F; Cui E; Pan R
    Cell Tissue Bank; 2024 Jun; 25(2):677-684. PubMed ID: 38466563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
    Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
    Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
    Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
    Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model.
    Kaspi H; Semo J; Abramov N; Dekel C; Lindborg S; Kern R; Lebovits C; Aricha R
    Stem Cell Res Ther; 2021 Jan; 12(1):72. PubMed ID: 33468250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives.
    Fernández-Francos S; Eiro N; González-Galiano N; Vizoso FJ
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
    Qin H; Zhao A
    Protein Cell; 2020 Oct; 11(10):707-722. PubMed ID: 32519302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review.
    Sadeghi B; Ringdén O; Gustafsson B; Castegren M
    Front Immunol; 2022; 13():963445. PubMed ID: 36426365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
    Can A; Coskun H
    Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome.
    Lopes-Pacheco M; Robba C; Rocco PRM; Pelosi P
    Cell Biol Toxicol; 2020 Feb; 36(1):83-102. PubMed ID: 31485828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene engineered mesenchymal stem cells: greater transgene expression and efficacy with minicircle vs. plasmid DNA vectors in a mouse model of acute lung injury.
    Florian M; Wang JP; Deng Y; Souza-Moreira L; Stewart DJ; Mei SHJ
    Stem Cell Res Ther; 2021 Mar; 12(1):184. PubMed ID: 33726829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of TGFβ1 in murine mesenchymal stem cells improves lung inflammation by impacting the Th17/Treg balance in LPS-induced ARDS mice.
    Chen J; Zhang X; Xie J; Xue M; Liu L; Yang Y; Qiu H
    Stem Cell Res Ther; 2020 Jul; 11(1):311. PubMed ID: 32698911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paracrine factors from mesenchymal stem cells: a proposed therapeutic tool for acute lung injury and acute respiratory distress syndrome.
    Li J; Huang S; Wu Y; Gu C; Gao D; Feng C; Wu X; Fu X
    Int Wound J; 2014 Apr; 11(2):114-21. PubMed ID: 24373614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomes in Pneumonia.
    Hezam K; Mo R; Wang C; Liu Y; Li Z
    Curr Pharm Biotechnol; 2022; 23(9):1153-1167. PubMed ID: 34493193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stromal Cells Attenuate Infection-Induced Acute Respiratory Distress Syndrome in Animal Experiments: A Meta-Analysis.
    Fengyun W; LiXin Z; Xinhua Q; Bin F
    Cell Transplant; 2020; 29():963689720969186. PubMed ID: 33164559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.